Prognostic value of risk stratification using blood biochemical parameters in Japanese patients with metastatic renal cell carcinoma treated by nivolumab

被引：0
|
作者：
Yamamoto, Yoshiaki
Matsuyama, Hideyasu
Matsumoto, Hiroaki
Sakano, Shigeru
Fujii, Nakanori
Oba, Kazuo
Yamamoto, Mitsutaka
Kamiryo, Yoriaki
Hiragino, Takeshi
Nagao, Kazuhiro
Takai, Kimio
Aoki, Akihiko
Yoshihiro, Satoru
Tsukamoto, Manabu
Akao, Jumpei
Kitahara, Seiji
Misumi, Taku
Komatsu, Hirotaka
Oka, Shintaro
Suga, Akinobu
机构：
[1] Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi, Japan
[2] Yamaguchi Univ, Ube, Yamaguchi, Japan
[3] Kokura Mem Hosp, Dept Urol, Kitakyushu, Japan
[4] Tokuyama Cent Hosp, Dept Urol & Nephrol, Shunan, Japan
[5] Saiseikai Yamaguchi Gen Hosp, Dept Urol, Yamaguchi, Japan
[6] Yamaguchi Grand Med Ctr, Dept Urol, Hofu, Japan
[7] Shimonoseki Saisekai Toyoura Hosp, Dept Urol, Shimonoseki, Yamaguchi, Japan
[8] Nagato Gen Hosp, Dept Urol, Nagato, Japan
[9] Shuto Gen Hosp, Yanai, Japan
[10] Saiseikai Shimonoseki Gen Hosp, Dept Urol, Shimonoseki, Yamaguchi, Japan
[11] Masuda Red Cross Hosp, Dept Urol, Masuda, Japan
[12] Shimonoseki City Hosp, Dept Urol, Shimonoseki, Yamaguchi, Japan
[13] Yamaguchi Red Cross Hosp, Dept Urol, Yamaguchi, Japan
[14] Ogori Daiichi Gen Hosp, Yamaguchi, Japan
[15] Sanyo Onoda Municipal Hosp, Sanyo Onoda, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
724
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Prognostic value of lymphnode metastases in patients with metastatic renal cell carcinoma
    Eggers, H.
    Tiemann, M. -L
    Peters, I
    Kuczyk, M. A.
    Ganser, A.
    Gruenwald, V
    Ivanyi, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 275 - 275
  • [22] Peripheral immunomodulatory changes in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab
    Almeida, Lorena
    Maia, Manuel
    Won, Haejung
    Moreira, Dayson
    Bergerot, Paulo
    Kortylewski, Marcin
    Pal, Sumanta
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [23] Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab
    Noel, Johanna
    Jouinot, Anne
    Alexandre, Jerome
    Ulmann, Guillaume
    Bretagne, Marie
    Castel-Ajgal, Zahra
    De Percin, Sixtine
    Vaquin-Villeminey, Clementine
    Revel, Marie-Pierre
    Peyromaure, Michael
    Boudou-Rouquette, Pascaline
    Arrondeau, Jennifer
    Gataa, Ithar
    Durand, Jean-Philippe
    Goldwasser, Francois
    Huillard, Olivier
    CANCERS, 2022, 14 (13)
  • [24] Association of Corticosteroids With Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab
    Lefort, Felix
    Dalban, Cecile
    Gross-Goupil, Marine
    Laguerre, Brigitte
    Chabaud, Sylvie
    Escudier, Bernard
    Albiges, Laurence
    JAMA ONCOLOGY, 2023, 9 (09) : 1295 - 1298
  • [25] Hypopituitarism in patients with metastatic renal cell carcinoma treated with ipilimumab and nivolumab combination therapy
    Takagi, Toshio
    Yoshida, Kazuhiko
    Kondo, Tsunenori
    Fukuda, Hironori
    Ishihara, Hiroki
    Kobayashi, Hirohito
    Iizuka, Junpei
    Ishida, Hideki
    Tanabe, Kazunari
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (12) : 1744 - 1750
  • [26] Prognostic stratification of patients with metastatic nasopharyngeal carcinoma using a clinical and biochemical scoring system
    Chee, Jeremy
    Loh, Kwok Seng
    Tham, Ivan
    Ho, Francis
    Wong, Lea Choung
    Tan, Chee Seng
    Goh, Boon Cher
    Lim, Chwee Ming
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (12) : 2563 - 2570
  • [27] Prognostic stratification of patients with metastatic nasopharyngeal carcinoma using a clinical and biochemical scoring system
    Jeremy Chee
    Kwok Seng Loh
    Ivan Tham
    Francis Ho
    Lea Choung Wong
    Chee Seng Tan
    Boon Cher Goh
    Chwee Ming Lim
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 2563 - 2570
  • [28] Prognostic value of liver metastasis in patients with esophageal squamous cell carcinoma treated with nivolumab
    Morita, Ryuichi
    Ishikawa, Takeshi
    Doi, Toshifumi
    Itani, Junichiro
    Sone, Daiki
    Iwai, Naoto
    Inoue, Ken
    Konishi, Hirotaka
    Dohi, Osamu
    Yoshida, Naohisa
    Shiozaki, Atsushi
    Uchiyama, Kazuhiko
    Takagi, Tomohisa
    Fujiwara, Hitoshi
    Konishi, Hideyuki
    Itoh, Yoshito
    ONCOLOGY LETTERS, 2025, 29 (03)
  • [29] Subcutaneous nivolumab versus intravenous nivolumab in patients with previously treated, advanced, or metastatic clear cell renal cell carcinoma
    Chacon, Matias Rodrigo
    Cutuli, Hernan J.
    Bracarda, Sergio
    Maruzzo, Marco
    Bourlon, Maria Teresa
    Jacobs, Carmel
    Perez-Valderrama, Begona
    Magri, Ignacio
    Richardet, Martin
    Centkowski, Piotr
    Fu, Simon Yuen Fai
    Gurman, Pablo
    Konduri, Srivani
    Yu, Zhuoxin
    Vezina, Heather
    George, Saby
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [30] Geriatric Nutritional Risk Index as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated with Nivolumab
    Fujiwara, Ryo
    Yuasa, Takeshi
    Yamamoto, Shinya
    Fujiwara, Motohiro
    Takemura, Kosuke
    Urasaki, Tetsuya
    Oki, Ryosuke
    Komai, Yoshinobu
    Oguchi, Tomohiko
    Numao, Noboru
    Yonese, Junji
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2023, 75 (02): : 670 - 677
12345